Masters of Health Magazine April 2025 | Page 93

Treating Alzheimer’s Disease Testimony

My mum, Eti, is 63 years old and has been diagnosed with severe Alzheimer’s disease. I approached Dr. Sircus 2 months ago when my mum was in a terrible physical and mental state. She hardly talked and did not manage to do anything by herself; she was very tense from the inside, bent over, and shuffled in her walk. Most of the day, she was in a zombie state.

She was treated, until my approach to Dr. Sircus, with conventional medications, which seemed to ruin her body and make her a Zombie. I had a strong feeling that it could not be that my mum would vanish so quickly and that there was nothing to do about it – as everyone believed.

For 3 weeks now, we have been giving my mum almost the full protocol, and the changes that are already happening are excellent compared to the terrible state she was in when starting. We are gradually taking her off the conventional medications (which include an anti-psychotic drug, anti-depression drug, and another drug “for Alzheimer”)

We are just beginning this journey, and she talks again – in complete sentences. Her shuffling walk is getting much better; she is standing almost straight, and most importantly, she is much more happy and connected to her environment. She laughs, makes jokes, enjoys the people around her, and enjoys films again. Most of the day, she is not a zombie at all! The day she remembered my name and called for me, I cried half the day.

Even though my mom still needs help in almost everything, her motor functions and her mental state are much better. I must say that 2 months ago, when we only started with the magnesium and sodium baths, that by itself helped her to be more relaxed.

I do not know what the limit of her improvement is, but we already see that Dr. Sircus’s protocol makes a change – and in her terrible disease – every small change is a big one.

I want to say that Dr. Sircus is a true partner in making my mom better, and his heart and mind are always open to us. I feel he is driven out of a deep care for human beings, and he is brave enough to check a new way that makes it possible for my mom to start to heal.

Maya from Israel.

Magnesium’s Neuroprotective Role

Magnesium deficiency, one of the core pillars of neurological degeneration, is overlooked in nearly every neurological assessment. Yet it plays a central role in blood vessel integrity, brain metabolism, and the calming of the nervous system. Without magnesium, the brain becomes electrically unstable, emotionally erratic, and metabolically starved. Strokes and heart attacks attributed to “natural causes” often stem from long-standing magnesium depletion. Magnesium helps reduce inflammation all over the body, including the brain.

Magnesium is essential for numerous physiological processes, including nerve transmission and muscle function. Its deficiency has been linked to various neurological disorders. Adequate magnesium levels are crucial for maintaining vascular health and neuronal function and protecting against excitotoxicity, all of which are vital in the context of Alzheimer’s disease.

Cyclodextrins: Opening Blood Flow and Clearing Cellular Debris

Used initially to dissolve cholesterol-based plaques in cardiovascular medicine, cyclodextrins have promising implications for the brain. Their ability to:

  • Solubilize and remove intracellular debris

  • Enhance endothelial function

  • Improve microvascular blood flow

  • Cyclodextrins are ideal for supporting cerebral circulation. In Alzheimer’s, where brain blood flow can drop by up to 30% in key areas, restoring perfusion is essential. Cyclodextrins don’t just unclog peripheral arteries. They penetrate deep tissue, bind to harmful lipids and toxins, and assist in cleansing vascular pathways—including those to the brain. Helping clear cholesterol deposits and plaque allows oxygen, nutrients, and natural medicines to reach regions long cut off by microvascular collapse.

    Cyclodextrins, cyclic oligosaccharides, have garnered attention for their ability to interact with lipids and influence membrane dynamics. Research indicates that cyclodextrins can assist in the treatment of neurological disorders by interacting with plasma membranes and extracting different lipids, which is relevant at the level of the blood-brain barrier (BBB). This property suggests that cyclodextrins could enhance the delivery of therapeutic agents to the brain, potentially improving outcomes in neurodegenerative diseases.

    Pair this with molecular Hydrogen, and we begin a revolution. Hydrogen, the most selective antioxidant in the universe, is small enough to reach the innermost cellular compartments, quenching hydroxyl radicals and reducing oxidative stress in the brain. It not only protects brain cells—it awakens them.

    Molecular Hydrogen Therapy

    Recent studies have demonstrated that molecular Hydrogen (H₂) possesses significant neuroprotective properties. Its antioxidant and anti-inflammatory effects can ameliorate neuronal damage, maintain neuronal integrity, and potentially inhibit the progression of neurodegenerative diseases like Alzheimer’s. For instance, a study indicated that H₂ treatment alleviated temporary symptoms and had disease-modifying effects, suggesting its potential in AD management.

    Mercury Toxicity and Alzheimer’s: A Hidden Catalyst for Neurodegeneration

    Alzheimer’s disease, the most common form of dementia, is typically described in terms of amyloid plaques, tau tangles, and neuroinflammation. But beneath this mainstream narrative lies a silent contributor rarely acknowledged by conventional medicine: heavy metal toxicity, especially from mercury.

    Mercury is a potent neurotoxin. It accumulates in fatty tissues—including the brain—disrupting enzymatic function, mitochondrial energy production, and most notably, depleting glutathione, the body’s master antioxidant. The central nervous system is particularly vulnerable, and long-term exposure to mercury, even in small amounts, has been shown to mimic the very patterns of neurological degeneration observed in Alzheimer’s.

    Multiple studies and clinical observations have drawn attention to this connection:

  • Mercury disrupts tubulin polymerization, a key structural component of neurons—just as tau tangles do.

  • Mercury increases oxidative stress, leading to inflammation and cellular damage.

  • Mercury impairs glutamate clearance, contributing to excitotoxicity and synaptic failure.

  • <<Read More>>